Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.22 USD | -0.81% | -3.94% | +20.79% |
Kurzporträt
Mitarbeiterzahl: 58
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
William Chou
CEO | Chief Executive Officer | 51 | 10.10.22 |
James M. Wilson
FOU | Founder | - | 01.07.17 |
Director of Finance/CFO | 48 | 01.11.21 | |
Mark Forman
CTO | Chief Tech/Sci/R&D Officer | 60 | 30.07.21 |
Andrea Campanile
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alex Fotopoulos
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.07.19 |
Investor Relations Contact | - | 01.02.21 | |
Edgar Cale
LAW | General Counsel | 60 | 01.09.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Maxine Gowen
CHM | Chairman | 66 | 18.02.21 |
Michael Kamarck
BRD | Director/Board Member | 73 | 02.07.22 |
Saqib Islam
BRD | Director/Board Member | 54 | 29.03.19 |
Director/Board Member | 52 | 01.02.20 | |
Director/Board Member | 53 | 01.12.19 | |
Derrell Porter
BRD | Director/Board Member | 53 | 27.05.21 |
William Chou
CEO | Chief Executive Officer | 51 | 10.10.22 |
Dolan Sondhi
BRD | Director/Board Member | - | 27.07.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 61 611 796 | 61 414 675 ( 99,68 %) | 0 | 99,68 % |
Unternehmenskontakt
Passage Bio, Inc.
One Commerce Square 2005 Market Street
19103, Philadelphia
+
http://www.passagebio.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+20.79% | 75.78 Mio. | |
-1.32% | 105 Mrd. | |
+3.87% | 97.5 Mrd. | |
+1.86% | 22.19 Mrd. | |
-16.44% | 21.33 Mrd. | |
-8.49% | 18.68 Mrd. | |
-42.33% | 16.6 Mrd. | |
-20.24% | 14.52 Mrd. | |
+5.78% | 14.09 Mrd. | |
+27.61% | 10.99 Mrd. |
- Börse
- Aktien
- A2P0EQ Aktie
- Unternehmen Passage Bio, Inc.